[Good practices in epidemiological surveillance for the sustainability of measles, rubella, and congenital rubella syndrome elimination in El Salvador, 2019-2023Boas práticas de vigilância epidemiológica para a sustentabilidade da eliminação do sarampo, da rubéola e da síndrome da rubéola congênita em El Salvador, 2019-2023].

IF 2 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Revista Panamericana De Salud Publica-pan American Journal of Public Health Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI:10.26633/RPSP.2024.118
Ana María Barrientos Llovet, Mayra Vanessa Ruballo de Gutiérrez, Ana Yamileth Hernández Martínez, Rosa Nohemí Jiménez, Eddy Alberto Chacón Aguirre, David Daniel Rivera Rosales, Gustavo Misael Ramírez
{"title":"[Good practices in epidemiological surveillance for the sustainability of measles, rubella, and congenital rubella syndrome elimination in El Salvador, 2019-2023Boas práticas de vigilância epidemiológica para a sustentabilidade da eliminação do sarampo, da rubéola e da síndrome da rubéola congênita em El Salvador, 2019-2023].","authors":"Ana María Barrientos Llovet, Mayra Vanessa Ruballo de Gutiérrez, Ana Yamileth Hernández Martínez, Rosa Nohemí Jiménez, Eddy Alberto Chacón Aguirre, David Daniel Rivera Rosales, Gustavo Misael Ramírez","doi":"10.26633/RPSP.2024.118","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Describe good practices in epidemiological surveillance implemented in El Salvador between 2019 and 2023 to sustain the elimination of measles, rubella, and congenital rubella syndrome.</p><p><strong>Methods: </strong>Special descriptive report on the implementation of good epidemiological and laboratory surveillance practices for measles, rubella, and congenital rubella syndrome from 2019 to 2023.</p><p><strong>Results: </strong>During the period 2019 to 2023, El Salvador reported no confirmed cases of measles, rubella, or congenital rubella syndrome. The national measles and rubella notification rate was 8.4 per 100 000 population in 2023; 9 in 2022; 5.6 in 2021; 2.9 in 2020; and 8.2 in 2019. Between the report of the first confirmed case of COVID-19 in the country and the declaration of the end of the international health emergency by the World Health Organization on 5 May 2023, the rate of reported suspected cases of measles and rubella remained above the indicator.</p><p><strong>Conclusions: </strong>The implementation of permanent and mandatory epidemiological surveillance strategies allowed the sustainability of measles and rubella elimination in El Salvador during the COVID-19 pandemic.</p>","PeriodicalId":21264,"journal":{"name":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","volume":"48 ","pages":"e118"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11648102/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26633/RPSP.2024.118","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Describe good practices in epidemiological surveillance implemented in El Salvador between 2019 and 2023 to sustain the elimination of measles, rubella, and congenital rubella syndrome.

Methods: Special descriptive report on the implementation of good epidemiological and laboratory surveillance practices for measles, rubella, and congenital rubella syndrome from 2019 to 2023.

Results: During the period 2019 to 2023, El Salvador reported no confirmed cases of measles, rubella, or congenital rubella syndrome. The national measles and rubella notification rate was 8.4 per 100 000 population in 2023; 9 in 2022; 5.6 in 2021; 2.9 in 2020; and 8.2 in 2019. Between the report of the first confirmed case of COVID-19 in the country and the declaration of the end of the international health emergency by the World Health Organization on 5 May 2023, the rate of reported suspected cases of measles and rubella remained above the indicator.

Conclusions: The implementation of permanent and mandatory epidemiological surveillance strategies allowed the sustainability of measles and rubella elimination in El Salvador during the COVID-19 pandemic.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[2019-2023年在萨尔瓦多持续消除麻疹、风疹和先天性风疹综合征的流行病学监测良好做法2019-2023年在萨尔瓦多持续消除麻疹、风疹和先天性风疹综合征的流行病学监测良好做法]。
目标:描述萨尔瓦多在 2019 年至 2023 年期间实施的流行病监测良好做法,以持续消除麻疹、风疹和先天性风疹综合征:描述萨尔瓦多在 2019 年至 2023 年期间为持续消除麻疹、风疹和先天性风疹综合征而实施的流行病学监测良好做法:关于 2019 年至 2023 年麻疹、风疹和先天性风疹综合征流行病学和实验室监测良好做法实施情况的特别描述性报告:在 2019 年至 2023 年期间,萨尔瓦多没有报告麻疹、风疹或先天性风疹综合征的确诊病例。2023 年,全国麻疹和风疹通报率为每 10 万人 8.4 例;2022 年为 9 例;2021 年为 5.6 例;2020 年为 2.9 例;2019 年为 8.2 例。从该国报告第一例 COVID-19 确诊病例到世界卫生组织于 2023 年 5 月 5 日宣布结束国际卫生紧急状态期间,麻疹和风疹疑似病例报告率一直高于指标:在 COVID-19 大流行期间,由于实施了永久性和强制性流行病监测战略,萨尔瓦多得以持续消除麻疹和风疹。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
3.80%
发文量
222
审稿时长
20 weeks
期刊最新文献
[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [Knowledge, practices, and human seroprevalence of brucellosis in the central dairy-producing area of Cochabamba, BoliviaConhecimentos, práticas e soroprevalência humana de brucelose na área central de produção de laticínios de Cochabamba, Bolívia]. Point prevalence survey of antibiotics in a pediatric tertiary hospital in the Republic of Panama. [Controlling cystic echinococcosis: outlook in the 21st centuryControle da equinococose/hidatidose cística: perspectivas no século XXI]. [Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1